REDUCED INTENSITY CONDITIONING WITH FLUDARABINE, CYCLOPHOSPHAMIDE, AND HIGH DOSE RITUXAN FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR FOLLICULAR LYMPHOMA: A PHASE II MULTICENTER TRIAL FROM THE BLOOD AND MARROW TRANSPLANT NETWORK (BMT CTN)

Allogeneic hematopoietic cell transplantation (alloHCT) can induce long term remissions in chemosensitive relapsed follicular lymphoma (FL). The BMT CTN conducted a multicenter phase 2 trial to examine the efficacy of alloHCT using reduced intensity conditioning (RIC) with rituximab (RTX) in multipl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Laport, Ginna G, Wu, Juan, Logan, Brent, Bachanova, Veronika, Hosing, Chitra, Fenske, Timothy, Longo, Walter, Devine, Steven M, Nademanee, Auayporn, Gersten, Iris, Horowitz, Mary, Lazarus, Hillard M, Riches, Marcie L
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949103/
https://ncbi.nlm.nih.gov/pubmed/27118571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.04.014
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares